Fundraising Fox
🦊/People
Sign in

George Golumbeski

Investor

Partner at Droia Ventures · Board director at Judo Bio

London, England, United Kingdom

Find your path to George

117 people in our graph share verified history with George — schools, employers, funds. One of them is your warm intro.

George RobertsunlockedGeorge: together at University of Wisconsin-Madison (1979)
×4George: together at University of Wisconsin-Madison
×5George: together at University of Virginia
×2George: together at Elan Pharmaceuticals

About

George Golumbeski is a Partner at Droia Ventures and works as an independent board member and advisor to biotechnology companies. He serves as a Director at MorphoSys AG and Sage Therapeutics, and as Chair of Carrick Therapeutics and Shattuck Labs. His areas of expertise include biotechnology corporate development transactions, corporate strategy, and the development of CNS, oncology, and inflammation therapeutics.

Contact· self-published, not guessed

Board director at Judo Bio

Intro paths

→

In turn, George can intro founders to Judo Bio's investors below.

Judo Bio's investors · 5

Atlas VentureCambridge · $500K – $1M checks · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024Droia VenturesLuxembourg · $540K checksThe Column GroupSan Francisco · $30M checks · since 2023YK BioventuresBurlingame

Co-founders at Judo Bio

AFAndrew Fraley
Andrew FraleyCo-founder
ASAlfica Sehgal
Alfica Sehgal

Experience

  1. DROIA VenturesPartner at DROIA VENTUREScurrent2020 — presentGreater NYC Area
  2. Independent ConsultantIndependent Biotechnology Executivecurrent2018 — presentGreater New York City Area
  3. CelgeneExecutive Vice President Business Development2009 — 2018Greater New York City Area
  4. NovartisVice President Business Development, Licensing, and Strategy2002 — 2008
  5. Elan PharmaceuticalsVice President - R&D Business Development2001 — 2002
  6. Schwarz PharmaVice President of Corporate Development1997 — 2000

Skills & more

Pharmaceutical Industry99Clinical Development54Biotechnology99Divestitures20Lifesciences43Oncology88Infection9Biomarkers1Business Development21Biopharmaceuticals28Business Strategy9CRO6
+12 moreCTMSCardiologyClinical TrialsCommercializationCorporate DevelopmentDermatologyDiabetesDrug DevelopmentLeadershipManagementStrategyFDA

From George's professional profile.

Colleagues at Droia Ventures

Dieter Petit
Senior Associate at Droia Ventures
Janwillem Naesens
Managing Partner at Droia Ventures
Lawrence Van Helleputte
Associate at Droia Ventures
Lisa Boden Shah
Partner at Edition Capital
Luc Dochez
Managing Partner at Droia Ventures
Mathias Declercq
Senior Associate at Droia Ventures
Matt Pavia
Director at Standard Investments
Matthias Van Woensel
Partner at Droia Ventures

Frequently asked questions

Who is George Golumbeski?
George Golumbeski is a Partner at Droia Ventures and works as an independent board member and advisor to biotechnology companies. He serves as a Director at MorphoSys AG and Sage Therapeutics, and as Chair of Carrick Therapeutics and Shattuck Labs. His areas of expertise include biotechnology corporate development transactions, corporate strategy, and the development of CNS, oncology, and inflammation therapeutics.
Where does George Golumbeski work?
George Golumbeski is Partner at Droia Ventures and Board director at Judo Bio.
Where did George Golumbeski go to school?
George Golumbeski studied at University of Wisconsin-Madison (PhD, Genetics / Molecular Biology); University of Virginia (BA, Biology).

Same school

Shared employers